Overview

Corticosteroid Nasal Spray in COVID-19 Anosmia

Status:
Completed

Trial end date:
2020-11-03

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the role of the topical corticosteroids nasal spray (mometasone furoate nasal spray) in improving anosmia in patients recovered from COVID-19 infection.

Phase:

Phase 3

Details

Lead Sponsor:

Benha University

Treatments:

Mometasone Furoate